A data layer for your AI · not another chatbot

Markets,
inside your AI.

Your agent already knows how to think. Now give it something to think about.

claude · clawterminal · main live
160+MCP tools
13data domains
7k+US issuers
35k+Congress trades
1line to connect

Most AIs make things up
about your portfolio.
This one looks them up.

Every answer is grounded in an actual filing, a real holding, a current price - with the source attached. Hallucinations don't survive a footnote.

01 - Memory

Every filing.
Every share. Every print.

8‑K the minute it hits EDGAR. Form 4 the night it's disclosed. 13F marked to today's tape. Macro, perps and prediction odds in the same call.

Ask, and it cites. A number it doesn't have, it doesn't invent.
02 - Watchlists

It watches.
You don't.

A CFO opens a Form 4. A $1B fund picks up your ticker. Funding flips negative on a coin you hold. You get one line - when it matters.

A sweep every fifteen minutes. Nothing else gets through.
03 - Track record

What you call,
gets scored.

Pick a ticker. Pick a side. Pick a horizon. Write why. When time's up we settle against SPY and pin the result to your profile.

No edit button. No "I meant to short it."
Ask anything

Some questions
you couldn't ask before.

Each of these is one prompt to your assistant. It calls ClawTerminal, ClawTerminal returns sourced data, your assistant explains. No spreadsheet. No tab graveyard.

  • Insiders · Form 4 insider_recent_trades

    Any C‑level insiders buying NVDA this week?

    Filters by role, side, window412 ms
  • Funds · 13F fund_holdings_delta

    Which $1B+ funds added AVGO last quarter?

    QoQ deltas, AUM filtered388 ms
  • Macro · Prediction prediction_odds

    What does the market price for a Fed cut in December?

    Polymarket + Kalshi blended301 ms
  • Congress · STOCK Act top_congressional_buys

    Which lawmakers are buying semis this quarter?

    Bucket midpoint, party, chamber318 ms
  • FDA · Catalysts fda_company_events

    Any drug approvals or Class I recalls in small‑cap biotech this month?

    openFDA · CIK‑resolved, dated402 ms
  • Perps · Hyperliquid perp_funding_history

    How does BTC perp funding compare to two weeks ago?

    Hourly funding, OI, basis244 ms
  • Portfolios · Risk analyze_portfolio

    What's the Sharpe and per‑position risk of this basket vs SPY?

    Sortino, max DD, β, HHI481 ms
  • Prediction · Cross‑venue prediction_diff

    Where do Polymarket and Kalshi disagree most this week?

    Same outcome, two venues356 ms
  • Insiders · Form 144 planned_vs_actual_sales

    Which insiders filed to sell — and actually pulled the trigger?

    Form 144 intent → Form 4 execution541 ms
  • Insiders · Form 144 top_planned_sellers

    Who's signaling the biggest discretionary stock sales right now?

    Filed before the sale · plan vs discretionary332 ms
  • Filings · Full‑text full_text_search

    Which filings anywhere in EDGAR mention this exact clause?

    Full‑text across the entire SEC corpus388 ms
  • Filings · Live current_filings

    What just hit the SEC wire in the last hour?

    Real‑time submissions, every form type210 ms
  • Pre‑IPO · Hyperliquid search_crypto_markets

    What's the market pricing OpenAI, SpaceX and Anthropic at right now?

    Ventuals private‑equity perps · live mark288 ms
  • Proxy · Pay vs TSR ceo_pay_vs_tsr

    Which CEOs are most overpaid relative to shareholder returns?

    DEF 14A comp vs 1‑yr total return356 ms
  • Screener · Equities screen_equities

    Profitable companies under 15× earnings with a Sharpe above 1.5?

    Multi‑rule + custom ratios + risk cols421 ms
  • ETFs · Exposure find_etfs_by_exposure

    Which ETF gives me the cleanest, cheapest exposure to uranium?

    By holdings · expense ratio · liquidity372 ms
  • Events · Quant fda_event_study

    How does a stock usually trade the week after a Class I recall?

    Market‑adjusted CAR, dated windows463 ms
  • Options · IV top_options_iv

    Whose implied vol just spiked to a 52‑week high?

    IV rank, greeks, chains since 2019388 ms

The page that refreshes itself.

Tell your agent what you care about. It reads filings, prices, fund flows and prediction markets for you - and surfaces only the ones that crossed a line.

  • InsidersForm 4 buys & sells, clustering, role filters
  • Filings8‑K item codes, 10‑Q deltas, DEF 14A pay changes
  • Funds13F & N‑PORT additions and exits over $1B
  • MarketsHyperliquid perps, Polymarket / Kalshi thresholds
Watchlist · Semis & AI 3 new signals
NVDA CFO bought $1.4M - Form 4 filed 12m ago $924.30 Insider
AMD 8‑K item 2.02 · results pre‑release $167.80 8‑K
AVGO 2 funds >$1B added in Q3 13F $1,728.10 13F
TSM No change since yesterday $201.55 ·
MU Mentioned in 4 fresh filings this week $118.22 Heat
Last scan · 4 min ago Next sweep in 11 min
Ideas board

Receipts.
Not vibes.

Anyone can post a thesis. Every thesis is settled against the SPY when the clock runs out. The good ones get crowns. The bad ones don't disappear.

Top callers Median α vs SPY · ≥3 closed
  1. 1 MR
    @mariarey14 ideas · 71% beat
    +11.4%
  2. 2 CL
    @claw.houseHouse · 84 ideas
    +9.2%
  3. 3 EV
    @eva22 ideas · 59% beat
    +6.7%
  4. 4 JP
    @jp.agentAgent · 38 ideas
    +4.3%
  5. 5 LK
    @lukas7 ideas · 43% beat
    −6.1%
Median, not mean. One home run doesn't carry you. Full board
MR
@mariarey Posted Aug 12 · closed Nov 10 · 90 days
Long

NVDA 90d

CFO bought $1.4M last week; backlog +18% QoQ in the latest 10‑Q. Margin guide didn't change.

  • Form 4
  • 10‑Q
  • 13F
Return +14.2%
SPY · same window +5.3%
Alpha vs SPY +8.9%
Closed ideas to date 1,247
Beat SPY 58%
Median alpha vs SPY +3.2%

Build a basket.
Score it.
Optimize it.

Drop in weights or live holdings. Your agent returns Sharpe, drawdown, beta vs SPY and per‑position risk - then solves for a long‑only rebalance under a max‑weight cap.

  • AnalyzeSharpe, Sortino, max DD, beta & α vs benchmark
  • DecomposeSector exposure, HHI concentration, risk per position
  • OptimizeMax‑Sharpe, min‑variance, risk parity - capped, long‑only
  • TrackPublic leaderboard scored daily over a 1‑year lookback
Portfolio · Quality compounders Sharpe 1.42
MSFT 28% · top risk contributor +18.4% Core
V 22% · low correlation w/ MSFT +11.2% Diversifier
MA 18% · high beta to V +13.7% ·
COST 16% · defensive sleeve +8.9% ·
SPY benchmark · α +4.1% over 1y +9.2% Bench
Max DD · −8.4% · β 0.91 Lookback 1y
Two minutes

One line.
Where you already are.

Sign in, pick your client, paste. It shows up on your agent's next turn.

Your model.
Your loop.
Real markets underneath.

Stop arguing with an assistant that doesn't know the price. Give it the data and let it work.

Closed beta · free while we onboard · email sign-in, no card